Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Holgersen EM"'
Autor:
Holgersen EM; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Gandhi S; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Zhou Y; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Kim J; Deep Genomics, Inc., Toronto, Canada.; Graduate School of Medical Science and Engineering, KAIST, Daejeon, Republic of Korea.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Vaz B; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Bogojeski J; Deep Genomics, Inc., Toronto, Canada.; Providence Therapeutics, Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Bugno M; Deep Genomics, Inc., Toronto, Canada.; The Hospital for Sick Children, Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Shalev Z; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Cheung-Ong K; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Gonçalves J; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., O'Hara M; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Kron K; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Verby M; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Sun M; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Kakaradov B; Deep Genomics, Inc., Toronto, Canada.; Skyhawk Therapeutics, Waltham, Massachusetts, USA.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Delong A; Deep Genomics, Inc., Toronto, Canada.; Department of Computer Science and Software Engineering, Concordia University, Montreal, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Merico D; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667., Deshwar AG; Deep Genomics, Inc., Toronto, Canada.; This article was previously published in bioRxiv, Preprint DOI: https://doi.org/10.1101/2020.09.03.281667.
Publikováno v:
Nucleic acid therapeutics [Nucleic Acid Ther] 2021 Dec; Vol. 31 (6), pp. 392-403. Date of Electronic Publication: 2021 Aug 13.
Autor:
Holgersen EM; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Gillespie A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Leavy OC; Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.; Department of Health Sciences, University of Leicester, Leicester, UK., Baxter JS; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Zvereva A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Muirhead G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Johnson N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Sipos O; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Dryden NH; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Broome LR; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., Chen Y; Scientific Computing, The Institute of Cancer Research, London, UK., Kozin I; Scientific Computing, The Institute of Cancer Research, London, UK., Dudbridge F; Department of Health Sciences, University of Leicester, Leicester, UK., Fletcher O; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Olivia.Fletcher@icr.ac.uk., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. Syed.Haider@icr.ac.uk.
Publikováno v:
Nature protocols [Nat Protoc] 2021 Apr; Vol. 16 (4), pp. 2257-2285. Date of Electronic Publication: 2021 Apr 09.
Autor:
Peck B; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Bland P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Mavrommati I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Muirhead G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Cottom H; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Wai PT; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Maguire SL; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Barker HE; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Stem Cells and Cancer, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia., Morrison E; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Kriplani D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Yu L; Division of Cancer Biology, The Institute of Cancer Research, London, England, United Kingdom., Gibson A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Falgari G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Brennan K; Faculty of Life Sciences, University of Manchester, Manchester, England, United Kingdom., Farnie G; SGC Oxford, University of Oxford, Oxford, England, United Kingdom., Buus R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Marlow R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Breast Cancer Now Research Unit, King's College London, London, England, United Kingdom., Novo D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Knight E; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Guppy N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Kolarevic D; The Royal Marsden NHS Foundation Trust, London, England, United Kingdom., Susnjar S; Department of Medical Oncology, The Institute of Oncology and Radiology of Serbia, Belgrade, Serbia., Milijic NM; Department of Pathology and Cytology, The Institute of Oncology and Radiology of Serbia, Belgrade, Serbia., Naidoo K; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Gazinska P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Pancholi S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Martin LA; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Holgersen EM; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Cheang MCU; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, England, United Kingdom., Noor F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Postel-Vinay S; Department of Drug Development (DITEP), Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.; UMR981, ATIP-Avenir team, INSERM, Villejuif, France., Quinn G; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., McDade S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom., Krasny L; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Huang P; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom., Daley F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Wallberg F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Choudhary JS; Division of Cancer Biology, The Institute of Cancer Research, London, England, United Kingdom., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom., Tutt AN; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.; Breast Cancer Now Research Unit, King's College London, London, England, United Kingdom., Natrajan R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom. rachael.natrajan@icr.ac.uk.; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
Publikováno v:
Cancer research [Cancer Res] 2021 Feb 15; Vol. 81 (4), pp. 847-859. Date of Electronic Publication: 2021 Jan 28.
Autor:
Espiritu SMG; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Liu LY; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Rubanova Y; Department of Computer Science, University of Toronto, Toronto, ON M5S 3G4, Canada; Donnelly Centre for Cellular and Biomolecular Research, Toronto, ON M5S 3E1, Canada., Bhandari V; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Holgersen EM; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Szyca LM; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Fox NS; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Chua MLK; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., Yamaguchi TN; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Heisler LE; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Livingstone J; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Wintersinger J; Department of Computer Science, University of Toronto, Toronto, ON M5S 3G4, Canada; Donnelly Centre for Cellular and Biomolecular Research, Toronto, ON M5S 3E1, Canada., Yousif F; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Lalonde E; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Rouette A; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Salcedo A; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Houlahan KE; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Li CH; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada., Huang V; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada., Fraser M; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada., van der Kwast T; Department of Pathology and Laboratory Medicine, Toronto General Hospital/University Health Network, Toronto, ON M5S 1A1, Canada., Morris QD; Department of Computer Science, University of Toronto, Toronto, ON M5S 3G4, Canada; Donnelly Centre for Cellular and Biomolecular Research, Toronto, ON M5S 3E1, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada; Vector Institute for Artificial Intelligence, Toronto, ON M5G 1M1, Canada. Electronic address: quaid.morris@utoronto.ca., Bristow RG; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada. Electronic address: robert.bristow@manchester.ac.uk., Boutros PC; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON M5G 1L7, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON M5S 1A8, Canada. Electronic address: paul.boutros@oicr.on.ca.
Publikováno v:
Cell [Cell] 2018 May 03; Vol. 173 (4), pp. 1003-1013.e15. Date of Electronic Publication: 2018 Apr 19.